FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Endo Hit with $2 Billion Fine Over Opioid Sales

[ Price : $8.95]

Endo Health Solutions agrees to plead guilty in federal court and pay over $2 billion in penalties to resolve criminal and civil i...

FDA Denies Approval/Hearing on Vanda Stalled sNDA

[ Price : $8.95]

FDA declines to grant a hearing request by Vanda Pharmaceuticals on a stalled supplemental NDA for Hetlioz (tasimelteon) for treat...

Datex-Ohmeda Air Compressor Recall is Class 1

[ Price : $8.95]

FDA classifies as Class 1 a Datex-Ohmeda recall of its EVair 03 (Jun-air) air compressor (model numbers: 1609000 and 1609002) afte...

Allecra NDA Approval for Antibiotic

[ Price : $8.95]

FDA approves an Allecra Therapeutics NDA for Exblifep (cefepime/enmetazobactam) for treating complicated urinary tract infections.

Class 1 Correction Recall on Electrodes Updated

[ Price : $8.95]

FDA updates a Class 1 recall (correction) of Megadyne Medical Products Mega Soft patient return electrode models to reiterate the ...

FDA Guide on Informed Consent Key Info

[ Price : $8.95]

FDA posts a draft guidance on Key Information and Facilitating Understanding in Informed Consent Guidance for Sponsors, Investigat...

Antibody-Drug Conjugate Pharmacology Guide

[ Price : $8.95]

Federal Register notice: FDA makes available a final guidance entitled Clinical Pharmacology Considerations for Antibody-Drug Conj...

Device Recognized Consensus Standards Updated

[ Price : $8.95]

Federal Register: FDA announces a publication containing modifications the agency is making to the list of standards it recognizes...

J&J Gets Full Approval for Rybrevant

[ Price : $8.95]

FDA grants full approval to Johnson & Johnsons Rybrevant (amivantamab-vmjw) in combination with chemotherapy for the first-line tr...

CDRH Cautions on Breast Implant Removal

[ Price : $8.95]

CDRHs Binita Ashar says a recent journal article on breast implant risk provided useful information for patients and providers abo...